Admissions

• California
• Massachusetts

Recognitions

Starting in 2020, Chambers has ranked Matt as Band 4 in product liability and mass torts; before that, he was ranked as "Up and Coming" in 2015 and 2016 and as Band 5 in 2017 through 2019. In 2017 and 2018, Legal 500 ranked him as a "Next Generation Lawyer." Clients have commented that Matt is "incredibly smart and practical – he can shape effective strategies in understandable and presentable ways"; he "has a great way of explaining issues in a user-friendly way," with a "very good sense of . . . business issues"; and he is "the type of lawyer who really gets invested in your interests." Other clients have said Matt is "absolutely detail-oriented and on top of every issue in the case," a "very good tactician," an "excellent, excellent lawyer," and "someone I would call out as really fantastic." Since 2018, Matt has been selected for inclusion in Who's Who Legal: Life Sciences for Product Liability.

Education

• J.D., Stanford University 2000
  Order of the Coif
  Teaching Assistant, Federal Litigation
  Associate Editor, Stanford Law Review
  Senior Editor, Stanford Law and Policy Review
  Co-President, Stanford Law Students Association
• B.A., Harvard University 1995
  magna cum laude
  Social Studies
  Phi Beta Kappa
  Truman Scholar

Courts

• All California state and federal district courts
• All Massachusetts state courts
• United States Court of Appeals for the Ninth Circuit
• United States Court of Appeals for the Seventh Circuit

Memberships

• Member of Law360's 2021 Life Sciences Editorial Board
• Boston Bar Association (2006 – present)
• Defense Research Institute (2003 – present)

Clerkships and Other Relevant Professional Experience

• Law Clerk to Hon. Charles R. Breyer, US District Court for Northern District of California (2000 – 2001)
• Extern to Hon. Napoleon A. Jones, US District Court for the Southern District of California (1998)
• Teaching Experience: Matt has taught, co-taught or prepared lectures on the following topics for courses at Harvard Law School and Yale Law School: (1) the regulatory system governing pharmaceutical, biotech and medical device companies; (2) how to litigate complex multi-jurisdictional product liability suits, including the coordination of these cases with related litigation such as government investigations, securities litigation, trade secret litigation and putative class actions; (3) the use of scientific data and other expert evidence in complex litigation; (4) the selection of plaintiffs for bellwether trials in mass torts; (5) the resolution of mass torts; and (6) the role of lawyers as strategic advisors.